ArticlemAbs

Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.

Nathalie Fournier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.